PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Volume: 15, Issue: 12, Pages: e0243900 - e0243900
Published: Dec 14, 2020
Abstract
Gastroenteropancreatic neuroendocrine neoplasms grade 3 (GEP-NENs G3) are rare tumors. These highly aggressive neoplasms are traditionally treated with platinum-based chemotherapy in combination with etoposide. Immune checkpoint proteins such as programmed cell death ligand (PD-L1) may have a role in different cancers allowing them escape the immune system and hence, progress. We aimed to investigate the immunohistochemical expression of PD-L1...
Paper Details
Title
PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
Published Date
Dec 14, 2020
Journal
Volume
15
Issue
12
Pages
e0243900 - e0243900
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.